Evofem Biosciences (EVFM) Announces Issuance of U S Patent Covering Phexxi Composition of Matter streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The US Court of Appeals for the Federal Circuit affirmed a district court’s finding of noninfringement in a Hatch-Waxman case under 35 U.S.C. § 271(e)(2) and § 271(a)-(b). The Court.
When there are multiple ANDA filers for the same drug, it may not be possible for a branded pharmaceutical company to bring Hatch-Waxman Act patent infringement suits against all of.
SOLANA BEACH, Calif., Aug. 10, 2022 Evoke Pharma, Inc. , a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases, today announced its financial results. | August 10, 2022